Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium Identifier:
First received: April 17, 2013
Last updated: April 8, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)